Publications by authors named "Hui-ping Wan"

Claim this Profile
U
UNC0638, a G9a inhibitor, suppresses epithelial‑mesenchymal transition‑mediated cellular migration and invasion in triple negative breast cancer.
Xiang-Rong Liu, Li-Hua Zhou, Jian-Xin Hu, Li-Min Liu, Hui-Ping Wan

Mol Med Rep· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cod skin peptide reduces chemotherapy-induced toxicity in gastric cancer patients.
Li-Ping Wu, Xiao-Fei Hu, Hui-Ping Wan, Yan-Min Yu, Jian-Hua Yu

Asia Pac J Clin Nutr· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety analysis of weekly paclitaxel plus S-1 versus paclitaxel plus 5-fluorouracil/calcium folinate as first-line therapy in advanced gastric cancer: a multicenter open random phase II trial.
Ting Deng, Nong Xu, Jian-Ping Xiong, Zhao Yan, Zhi-Xiang Zhuang, Hui-Ping Wan, Mei-Ling Wang

J Chemother· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A phase II prospective randomized controlled trial of weekly paclitaxel combined with S-1 or fluorouracil for advanced gastric carcinoma].
Ding-zhi Huang, Jian-ping Xiong, Nong Xu, Zhao Yan, Zhi-xiang Zhuang, Hui-ping Wan, Mei-Ling Wang

Zhonghua Zhong Liu Za Zhi· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis